GB1158283A - Composition to be Applied to Skin and Process for Preparing Same. - Google Patents
Composition to be Applied to Skin and Process for Preparing Same.Info
- Publication number
- GB1158283A GB1158283A GB4455866D GB4455866D GB1158283A GB 1158283 A GB1158283 A GB 1158283A GB 4455866 D GB4455866 D GB 4455866D GB 4455866 D GB4455866 D GB 4455866D GB 1158283 A GB1158283 A GB 1158283A
- Authority
- GB
- United Kingdom
- Prior art keywords
- agent
- acid
- derivatives
- pharmaceutically acceptable
- coal tar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract 3
- 150000001408 amides Chemical class 0.000 abstract 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Substances 0.000 abstract 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- -1 alkyl radical Chemical class 0.000 abstract 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 abstract 2
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 2
- 230000000340 anti-metabolite Effects 0.000 abstract 2
- 229940100197 antimetabolite Drugs 0.000 abstract 2
- 239000002256 antimetabolite Substances 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 2
- 239000011280 coal tar Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003974 emollient agent Substances 0.000 abstract 2
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 2
- 229960004889 salicylic acid Drugs 0.000 abstract 2
- 239000003981 vehicle Substances 0.000 abstract 2
- YEVVXURMULIHJU-UHFFFAOYSA-M (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclohexyl-2-hydroxy-2-phenylacetate;bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCCC1 YEVVXURMULIHJU-UHFFFAOYSA-M 0.000 abstract 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 abstract 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 abstract 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 abstract 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 abstract 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 abstract 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- 239000004166 Lanolin Substances 0.000 abstract 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000004104 Oleandomycin Substances 0.000 abstract 1
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 239000000058 anti acne agent Substances 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 229940124340 antiacne agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 239000012965 benzophenone Substances 0.000 abstract 1
- 150000008366 benzophenones Chemical class 0.000 abstract 1
- 229960004311 betamethasone valerate Drugs 0.000 abstract 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 abstract 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960005091 chloramphenicol Drugs 0.000 abstract 1
- 229940097572 chloromycetin Drugs 0.000 abstract 1
- 229930016911 cinnamic acid Natural products 0.000 abstract 1
- 235000013985 cinnamic acid Nutrition 0.000 abstract 1
- 229940057004 coal tar extract Drugs 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229960001347 fluocinolone acetonide Drugs 0.000 abstract 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 abstract 1
- 229960002949 fluorouracil Drugs 0.000 abstract 1
- 150000002334 glycols Chemical class 0.000 abstract 1
- 229960004068 hexachlorophene Drugs 0.000 abstract 1
- 229950006188 hexopyrronium bromide Drugs 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 229940039717 lanolin Drugs 0.000 abstract 1
- 235000019388 lanolin Nutrition 0.000 abstract 1
- 229940099367 lanolin alcohols Drugs 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 229960001428 mercaptopurine Drugs 0.000 abstract 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 abstract 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 abstract 1
- 229960000988 nystatin Drugs 0.000 abstract 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 abstract 1
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 abstract 1
- 229960002351 oleandomycin Drugs 0.000 abstract 1
- 235000019367 oleandomycin Nutrition 0.000 abstract 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000516 sunscreening agent Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 229940040944 tetracyclines Drugs 0.000 abstract 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 229960002117 triamcinolone acetonide Drugs 0.000 abstract 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 abstract 1
- KVSKGMLNBAPGKH-UHFFFAOYSA-N tribromosalicylanilide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(Br)C=C1 KVSKGMLNBAPGKH-UHFFFAOYSA-N 0.000 abstract 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 abstract 1
- 229960002703 undecylenic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1,158,283. Compositions for topical application. FOSTER-MILBURN CO. 5 Oct., 1966 [21 Oct., 1965], No. 44558/66. Heading A5B. Compositions to be applied to the skin and having increased percutaneous absorption through and retention in skin comprise a stable, topically active chemical compound (e.g. an anti-acne agent, an anti-inflammatory agent, an anticholinergic, an emollient, a sex hormone, crude coal tar, an antipsoriatic agent or an antimetabolite) solubilized in a pharmaceutically acceptable vehicle having as one component an amide having the structural formula wherein R<SP>1</SP> is H or Me, R<SP>2</SP> is H or an alkyl radical containing not more than 2 carbon atoms, and R<SP>3</SP> is an alkyl radical containing not more than 2 carbon atoms. The amide is preferably N,N-dimethyl acetamide, N,N- dimethyl formamide or N,N-diethyl acetamide. The topically active chemical compound may be an anti-inflammatory agent, e.g. triamcinolone acetonide, fluocinolone acetonide, betamethasone valerate, flurandren alone acetonide and hydrocortisone, an anticholinergic e.g. hexopyrronium bromide, an antimetabolite e.g. 5-fluorouracil, 4-amino-n<SP>10</SP>-methylpteroylglutamic acid and b-mercaptopurine; an antimicrobial agent e.g. erythromycin, tetracyclines, chloromycetin, oleandomycin, chloramphenicol, 2,2'-methylenebis (3,4,6-trichlorophenol), 3,4',5-tribromosalicylanilide, 3,4,4'- trichlorocarbanilide, nystatin, undecylenic acid, sulphur, salicylic acid, parachlorometaxylenol, 2-(4'-thiazolyl)-benzimidazole, iodine, iodochlorhydroxyguin- and 5-iodo-2'-deoxyuridine, an emollient e.g. lanolin and lanolin alcohols and their ethoxylated and/or acetylated products, glycerol, glycols and their derivatives, fatty acids, their esters, alcohols and derivatives; a sex hormone e.g. testosterone and oestradial; a sunscreen agent e.g. para-aminobenzoic acid, amyl p-dimethylaminobenzoate, cinnamic acid and benzophenones and their derivatives and coal tar products including anthracene and a composition containing sulphur, salicylic acid, hexachlorophene and crude coal tar extract. The amides may be used alone or in combination with other additional pharmaceutically acceptable surface active agents, emulsifiers, solvents, vehicles or other pharmaceutically acceptable bases.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49933065A | 1965-10-21 | 1965-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1158283A true GB1158283A (en) | 1969-07-16 |
Family
ID=23984853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4455866D Expired GB1158283A (en) | 1965-10-21 | 1966-10-05 | Composition to be Applied to Skin and Process for Preparing Same. |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1158283A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2133690A (en) * | 1983-01-10 | 1984-08-01 | Young & Company Limited Robert | Percutaneous levamisole compositions |
| FR2547503A1 (en) * | 1983-05-20 | 1984-12-21 | Nitto Electric Ind Co | NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION |
| WO2008104532A1 (en) * | 2007-02-26 | 2008-09-04 | Galderma Research & Development | Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
| US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
-
1966
- 1966-10-05 GB GB4455866D patent/GB1158283A/en not_active Expired
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2133690A (en) * | 1983-01-10 | 1984-08-01 | Young & Company Limited Robert | Percutaneous levamisole compositions |
| FR2547503A1 (en) * | 1983-05-20 | 1984-12-21 | Nitto Electric Ind Co | NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION |
| US9132089B2 (en) | 2000-08-30 | 2015-09-15 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US8486925B2 (en) | 2005-10-12 | 2013-07-16 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8466137B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8729057B2 (en) | 2005-10-12 | 2014-05-20 | Unimed Pharmaeuticals, LLC | Testosterone gel and method of use |
| US8741881B2 (en) | 2005-10-12 | 2014-06-03 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8754070B2 (en) | 2005-10-12 | 2014-06-17 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8759329B2 (en) | 2005-10-12 | 2014-06-24 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
| WO2008104532A1 (en) * | 2007-02-26 | 2008-09-04 | Galderma Research & Development | Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4537776A (en) | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone | |
| DE69227672T2 (en) | Percutaneous absorption promoters, plasters and methods for promoting percutaneous absorption | |
| US4323558A (en) | Topical trien containing pharmaceutical compositions and methods of use | |
| KR930007444A (en) | Pharmaceutical composition containing 4-biphenylacetic acid (BPAA) | |
| US4130643A (en) | Dermatological compositions | |
| US3592930A (en) | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle | |
| DE3783683T2 (en) | SKIN PENETRATION-IMPROVING COMPOSITIONS. | |
| US3749773A (en) | Gelled steroid ointment | |
| GB1593786A (en) | Pharmaceutical formulations | |
| EP0129284A2 (en) | Improved penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | |
| JPH0420886B2 (en) | ||
| US3678156A (en) | Compositions for topical application to animal tissue and method of enhancing penetration thereof | |
| PT93638A (en) | A process for the preparation of a composition for the topical application of vitamin A | |
| US4048310A (en) | Topical steroid formulation in form of lotion or cream | |
| US4579844A (en) | Topical anti-inflammatory drug therapy | |
| GB1158283A (en) | Composition to be Applied to Skin and Process for Preparing Same. | |
| Munro et al. | Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. | |
| US2801202A (en) | Compositions containing cortisone or hydrocortisone with phenylephrine | |
| GB1472308A (en) | Steroidal topical cream base | |
| US3856954A (en) | Topical steroid compositions | |
| US3888995A (en) | Fatty alcohol-propylene glycol vehicle | |
| US4473565A (en) | Topical anti-inflammatory drug therapy | |
| Sneddon | Clinical use of topical corticosteroids | |
| IE41287L (en) | Steroid pharmaceutical composition | |
| US3689667A (en) | C22 acid and its salts to promote wound healing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] |